VIJI MELEDATH: Open Payments
NPI 1669962791 · WESTBURY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,596 in 54 payments from 8 companies in 2025. Trend: 2023 $1,257 · 2024 $1,542 · 2025 $1,596
Food & beverage: $1,596
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 19 | $716 |
| E.R. Squibb & Sons, L.L.C. | 10 | $305 |
| Lundbeck LLC | 6 | $120 |
| Alkermes, Inc. | 4 | $120 |
| Luye Pharma (USA) Ltd. | 4 | $95 |
| Teva Pharmaceuticals USA, Inc. | 5 | $94 |
| Otsuka America Pharmaceutical, Inc. | 4 | $91 |
| Janssen Pharmaceuticals, Inc | 2 | $56 |
Products named: INGREZZA, COBENFY, ABILIFY ASIMTUFII, ARISTADA, ERZOFRI EXTENDED-RELEASE, UZEDY, ABILIFY MAINTENA, SPRAVATO.
Industry payments across NY — which companies pay providers there.
